Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies. - Wikidata - awgldk - TriplyDB

Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

http://www.wikidata.org/entity/Q37158071

about

Diabetes mellitus and cognitive impairments Importance of Geriatric Syndromes in Older Patients with Diabetes with de novo Insulin Treatment: The VEGAS Study Aberrant Brain Regional Homogeneity and Functional Connectivity in Middle-Aged T2DM Patients: A Resting-State Functional MRI Study Strong Association between Plasma Dipeptidyl Peptidase-4 Activity and Impaired Cognitive Function in Elderly Population with Normal Glucose Tolerance.Lipoprotein-associated Phospholipase A2 Is Associated with Risk of Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes.Glucose regulation and face recognition deficits in older adults: the role of attention.Linking senile dementia to type 2 diabetes: role of oxidative stress markers, C-reactive protein and tumor necrosis factor-α.Cognition, serum BDNF levels, and BDNF Val66Met polymorphism in type 2 diabetes patients and healthy controls.

P2860

Q28079459-87D66351-1C7E-401E-8BDF-08FF8A13032B Q36942859-EDCC84EB-128A-41B9-B7D4-A0FE69CA1C25 Q37284699-E4FCA25B-2662-4C6A-B14F-752A31168FDA Q38629516-D7FFB6AD-58F3-464C-A612-F46DF8305CF4 Q42012439-352A53E3-D8DD-449A-9F76-6E101177C98E Q47570931-D1BED81E-BCD0-4849-AE79-3EB5F46C2745 Q47752917-2A7AE955-9780-4D21-BE7E-1349805E68BC Q49709684-72BDF53A-11D0-46ED-AABB-FFD3ED8A8D78

P2860

Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

http://www.wikidata.org/entity/Q37158071

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

@en

Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

@nl

type

label

Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

@en

Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

@nl

prefLabel

Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

@en

Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

@nl

P1433

Q37158071-80C26143-3C3B-40F8-BA05-B02F1DEEBD62

P1476

Q37158071-7AE0C3B5-E789-4380-996B-B325413D35C5

P2093

Q37158071-19C5BC58-D477-4454-931F-FB862A9B9B4D

Q37158071-423DC3FF-71E8-4355-A36C-3C064C4B5584

Q37158071-CA5ED0F4-4F80-492D-9DC1-06B5904AC640

P2860

Q37158071-021277EB-2A6E-4F54-9BB5-DC8149B75C77

Q37158071-045703B2-0E94-4285-B10D-5FDF90BF968D

Q37158071-052192C4-1F92-4FEF-80CB-01438B16B97C

Q37158071-071CB777-84A0-4417-A123-A402D00B2228

Q37158071-0A878767-11A5-41ED-B694-65835E3DCC74

Q37158071-0D76D420-2B3C-481F-94C0-5B593600A311

Q37158071-0E580EA8-0577-4414-8460-E633123C63B5

Q37158071-0F3AC80F-D47F-47F6-ACA1-8CB44F8A06D0

Q37158071-10EB2DA2-98AA-4047-A837-697EAF222B32

Q37158071-13DE7A43-94E1-4C1B-A78F-DEFA8C9B5DF0

P304

Q37158071-A779B1E8-4CED-4CB3-A789-7A80C69EF8FC

P31

Q37158071-728E23C2-59F2-479C-88B6-65C8B833B898

P356

Q37158071-7298000F-DF43-4801-8F57-6094208C693E

P433

Q37158071-DA730C64-B739-4B52-A369-306EA02F3AA4

P478

Q37158071-45324165-0A13-4AFE-B2D7-52191946EE4E

P577

Q37158071-5FB25582-8D23-4A92-9454-D234A00393EC

P698

Q37158071-682A889C-31DB-4CAE-8747-3B134F9B7E06

P921

Q37158071-EA8BDEC2-305F-4277-9A48-590A2E985F4D

P932

Q37158071-32537F41-4042-4EE5-A81E-F5FF2446FBE5

P356

J.ECL.2013.05.009

P1433

Endocrinology and Metabolism Clinics of North America

P1476

Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

@en

P2093

Efrat Kravitz

http://www.w3.org/2001/XMLSchema#string

James Schmeidler

http://www.w3.org/2001/XMLSchema#string

Michal Schnaider Beeri

http://www.w3.org/2001/XMLSchema#string

P2860

Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study

Insulin in the brain: there and back again

Mild cognitive impairment: clinical characterization and outcome

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice.

A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease.

Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status.

Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.

Diabetes is associated with increased rate of cognitive decline in questionably demented elderly.

P304

489-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ECL.2013.05.009

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24011882

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3767929

http://www.w3.org/2001/XMLSchema#string